The term ‘viral sepsis’ has gained popularity since the COVID-19 pandemic, but whether it is clinically useful or risks ...

A new Covid wave may hit this winter – but as the infection has become more like a cold or flu, most of us don’t need to ...

A dismantled health infrastructure leaves the U.S. incredibly vulnerable, warns infectious-disease expert Michael Osterholm.

Enanta Pharmaceuticals remains a Buy as zelicapavir shows promise in RSV trials; strong financials support growth. Read why ENTA stock remains a Buy.

For nearly two decades, just a passing mention of Erin Sullivan-Wagner's cancer was enough to 'quiet a room.' At the end of 2007, the Iowa mother-of-four had noticed specks of blood dotting her toilet ...

Health experts are warning people about the 'tripledemic' threat as cases of flu, RSV and the new Covid variant Stratus are ...

Today, the stock market opening can define which shares will be heroes or zeros. Investors and traders are watching key ...